- Home
- CAH vs AVB Comparison
CAH vs AVB Comparison
Compare CAH & AVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAH
- AVB
- Stock Information
- Founded
- CAH 1979
- AVB 1978
- Country
- CAH United States
- AVB United States
- Employees
- CAH N/A
- AVB N/A
- Industry
- CAH Other Pharmaceuticals
- AVB Real Estate Investment Trusts
- Sector
- CAH Health Care
- AVB Real Estate
- Exchange
- CAH Nasdaq
- AVB Nasdaq
- Market Cap
- CAH 30.3B
- AVB 32.2B
- IPO Year
- CAH N/A
- AVB 1994
- Fundamental
- Price
- CAH $118.30
- AVB $222.20
- Analyst Decision
- CAH Buy
- AVB Buy
- Analyst Count
- CAH 12
- AVB 17
- Target Price
- CAH $125.92
- AVB $227.00
- AVG Volume (30 Days)
- CAH 2.3M
- AVB 661.1K
- Earning Date
- CAH 01-30-2025
- AVB 01-29-2025
- Dividend Yield
- CAH 1.71%
- AVB 3.06%
- EPS Growth
- CAH 539.70
- AVB 11.26
- EPS
- CAH 5.21
- AVB 7.32
- Revenue
- CAH $224,454,000,000.00
- AVB $2,926,011,000.00
- Revenue This Year
- CAH N/A
- AVB N/A
- Revenue Next Year
- CAH $8.17
- AVB $4.75
- P/E Ratio
- CAH $22.71
- AVB $30.35
- Revenue Growth
- CAH 6.87
- AVB 7.84
- 52 Week Low
- CAH $93.17
- AVB $169.37
- 52 Week High
- CAH $126.23
- AVB $239.29
- Technical
- Relative Strength Index (RSI)
- CAH 48.44
- AVB 42.93
- Support Level
- CAH $115.00
- AVB $216.52
- Resistance Level
- CAH $126.23
- AVB $230.23
- Average True Range (ATR)
- CAH 2.61
- AVB 4.18
- MACD
- CAH -0.72
- AVB -1.06
- Stochastic Oscillator
- CAH 31.81
- AVB 38.67
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
About AVB AvalonBay Communities Inc.
AvalonBay Communities owns a portfolio of 281 apartment communities with over 87,000 units and is developing 18 additional properties with over 6,200 units. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington D.C., California, and the Pacific Northwest.